Abstract
Experimental models of neuroendocrine tumor disease are scarce, with only a few existing neuroendocrine tumor cell lines of pancreatic origin (panNET). Their molecular characterization has so far focused on the neuroendocrine phenotype and cancer-related mutations, while a transcription-based assessment of their developmental origin and malignant potential is lacking. In this study, we performed immunoblotting and qPCR analysis of neuroendocrine, epithelial, developmental endocrine-related genes as well as next-generation sequencing (NGS) analysis of microRNAs (miRs) on three panNET cell lines, BON-1, QGP-1, and NT-3. All three lines displayed a neuroendocrine and epithelial phenotype; however, while insulinoma-derived NT-3 cells preferentially expressed markers of mature functional pancreatic β-cells (i.e., INS, MAFA), both BON-1 and QGP-1 displayed high expression of genes associated with immature or non-functional β/δ-cells genes (i.e., NEUROG3), or pancreatic endocrine progenitors (i.e., FOXA2). NGS-based identification of miRs in BON-1 and QGP-1 cells revealed the presence of all six members of the miR-17–92 cluster, which have been implicated in β-cell function and differentiation, but also have roles in cancer being both oncogenic or tumor suppressive. Notably, both BON-1 and QGP-1 cells expressed several miRs known to be negatively associated with epithelial–mesenchymal transition, invasion or metastasis. Moreover, both cell lines failed to exhibit migratory activity in vitro. Taken together, NT-3 cells resemble mature functional β-cells, while both BON-1 and QGP-1 are more similar to immature/non-functional pancreatic β/δ-cells or pancreatic endocrine progenitors. Based on the recent identification of three transcriptional subtypes in panNETs, NT-3 cells resemble the “islet/insulinoma tumors” (IT) subtype, while BON-1 and QGP-1 cells were tentatively classified as “metastasis-like/primary” (MLP). Our results provide a comprehensive characterization of three panNET cell lines and demonstrate their relevance as neuroendocrine tumor models.
Highlights
Preclinical models of neuroendocrine tumors (NET) currently encompass only a limited number of human NET cell lines and mouse models
To verify or dismiss such a scenario, we evaluated in be the result of absent (BON), QGP, and NT-3 cells expression of Insulin, Glucagon, and SST by Quantitative Real-Time RT-PCR (qPCR) analysis
We showed that the BON and QGP cell lines display a neuroendocrine and well-differentiated phenotype, but, in contrast to the NT-3 line, do not exhibit a gene signature characteristic of mature/functional pancreatic islet/β-cells
Summary
Preclinical models of neuroendocrine tumors (NET) currently encompass only a limited number of human NET cell lines and mouse models. Their mutation patterns, and proliferation rates seem distinct from well-differentiated NETs in patients [5,6,7] and might not adequately reflect the tumor biology of well-differentiated NETs. for panNET, studies in BON and QGP cells have raised questions regarding their relevance as models due to the absence of mutations in MEN1 [5,6,7] or low SSTR expression [8]. For panNET, studies in BON and QGP cells have raised questions regarding their relevance as models due to the absence of mutations in MEN1 [5,6,7] or low SSTR expression [8] Together, this emphasizes the need for careful reevaluation and further characterization of the existing cell lines. One aim of the present study was; to confirm the authenticity of the BON and QGP cell lines with respect to their neuroendocrine and epithelial phenotype, developmental origin, and propensity for cell motility in vitro
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.